Giuseppe Cestone

Nephrologist from Irpinia 💚 I live and work in Florence

[Giuseppe Cestone @GCestone]

Ci siamo! #propagandalive #propagandatombola

[Propaganda Live @welikeduel]

Carmine del Grosso è andato a Cairano (AV) per un nuovo Bar Test
#propagandatop #propagandalive @carminedelbig https://t.co/GznOYHna77

[KDIGO @goKDIGO]

The draft of the KDIGO 2026 AKI/AKD Guideline is now available for public review through April 27, 2026.

Download the guideline and submit comments via the feedback form on the guideline website: https://t.co/6kEU9nONnb

This update to the 2012 guideline introduces a unified framework across AKI and AKD, with advances in diagnosis, prevention, and management, including updated recommendations on biomarkers, kidney replacement therapy, and follow-up care.

Recommendations were developed by an international Work Group, including patient representatives, using GRADE methodology.

KDIGO welcomes feedback from the global kidney community. Reviewers may focus on sections most relevant to their expertise, and contributors may be acknowledged in the final publication.

#AKI #AKD

[Nature Reviews Nephrology @NatRevNeph]

Potassium and the kidney https://t.co/NhzlvhyiOs

[Paola Romagnani @PRomagnani]

Our new study in Science is out! CKD progresses slower in females.
🔹Estrogens boost female renal progenitors to produce new podocytes for pregnancy adaptation.
🔹Loss of this mechanism causes preeclampsia, maternal CKD risk & fewer nephrons in offspring. https://t.co/P2ATMuV9ZE

[Kidney International @Kidney_Int]

A randomized controlled trial evaluated the efficacy and safety of #apixaban for prevention of recurrent thrombosis after #thrombectomy of #hemodialysis #vascularaccess

https://t.co/eyocsHisdX

[Paola Romagnani @PRomagnani]

This study was a collaboration with @UNI_FIRENZE @LMU_Muenchen @hbellvitge @fondazionemeyer @AOUCareggi. Special thanks to Valentina Raglianti, Maria Lucia Angelotti, Letizia De Chiara, Marco Allinovi, Benedetta Mazzinghi for their key contributions!
https://t.co/te9q16UEsc

[Sanjeev Sethi @SethiRenalPath]

Simple concept of GN. It’s all about location!

1. Subendothelial deposits/injury by Ig, immune-complexes, complement, other mechanism leads to influx of leukocytes= inflammation=GN

2. Subepithelial deposits/injury= protected by GBM & endothelial cells=no inflammation=No GN. 1/3

[Daniel Díaz - García @DanielDiazNF]

Management strategies for IgAN based on clinical presentations:

▫️Classic IgAN +/- proteinuria
▫️IgAN w/macrohematuria
▫️Pure nephrotic syndrome
▫️Rapidly progressive/Crescentic IgAN
▫️IgAN w/malignant HTN/TMA
▫️IgAN w/pregnancy
▫️Post transplant IgAN
🔗 https://t.co/gKXuuSXayM

[ASN Publications @asnpublications]

Rhabdomyolysis is a condition characterized by the destruction of skeletal muscle fibers and the release of intracellular contents into the bloodstream. This Kidney Case Conference: How I Treat article discusses treatment of rhabdomyolysis-induced AKI https://t.co/6v3wkxFiLx

[NephroPOCUS @NephroP]

Extracardiac #POCUS signs of fluid overload. (A) Internal jugular vein (IJV), (B) inferior vena cava (IVC), (C) hepatic venous flow, (D) portal venous flow, (E) optic nerve diameter, (F) transcranial Doppler, (G) 🫁 B-lines, and (H) renal interlobar vein Doppler.
#MedEd #Nephpearls #criticalcare
🔗 https://t.co/uNDDEpRjMi

[NDT @NDTsocial]

🥳NDT is proud to announce the new 2023-2024 Editorial Fellows!
🤝They will work hand-in-hand with our Associate Editors & will be involved in all aspects of the editorial process & medical publishing.
🙏Welcome to the team and thanks for your support!

[Kitching Laboratory @KitchingLab]

Free online access for this #vasculitis review from @DiseasePrimers (not downloadable or printable).
https://t.co/SfiaUCtTa0

[Hans-Joachim Anders @hjanders_hans]

1. Most drugs for GN act outside the kidney (spleen, lymph nodes, bone marrow)
2. Long pipeline of drugs for 3 of the 5 groups of GN that connect immunopathogenesis + immunotherapy
Now in @NatRevImmunol
@KitchingLab @PRomagnani, Nelson Leung
Free online: https://t.co/EGFkGBpC9p

[Nature Reviews Nephrology @NatRevNeph]

Algorithm for the diagnosis of primary aHUS https://t.co/3SjIDqaJAr

[Giuseppe Cestone @GCestone]

@giammylugli @ElenaLazzeri2 @letiziadechiara ...and Cestone!🙄

[Giuseppe Cestone @GCestone]

@EdoardoMelilli @xfulladosa @CouceiroCM @fgpreciado Felicidades chicos! Y la piramide?

[Francesca Becherucci @FrancescaBeche]

Improving diagnostic pathways in patients with podocytopathies is possible. Find out all the latest discoveries in our new review in @CKJsocial @cirluigi @samuela_land @RagliantiV https://t.co/b9ShXRdGih

[Valerio Lundini @valeriolundini]

Mercoledì alle 23.30 ricomincia su #rai2 la nuova stagione di #unapezzadilundini
Ecco qua

[Luigi Cirillo @cirluigi]

Expectations in children with glomerular diseases from SGLT2 inhibitors #flozinate https://t.co/JiptCnl5Xe